Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 4:19 pm Sale | 2025-09-30 | 13G | VERASTEM INC VSTM | Stonepine Capital Management, LLC | 2,670,032 4.300% | -163,301 (-5.76%) | Filing History |
| 2025-11-04 12:19 pm Purchase | 2025-10-29 | 13G | CNS PHARMACEUTICALS INC PA CNSP | Stonepine Capital Management, LLC | 32,220 5.600% | 32,220 (New Position) | Filing History |
| 2025-09-08 5:44 pm Purchase | 2025-09-02 | 13G | KEZAR LIFE SCIENCES INC NE KZR | Stonepine Capital Management, LLC | 377,240 5.200% | 377,240 (New Position) | Filing History |
| 2025-08-13 4:16 pm Purchase | 2025-06-30 | 13G | AYTU BIOPHARMA INC PAR $0. AYTU | Stonepine Capital Management, LLC | 906,063 9.900% | 279,201 (+44.54%) | Filing History |
| 2025-08-13 4:08 pm Purchase | 2025-06-30 | 13G | SURROZEN INC SRZN | Stonepine Capital Management, LLC | 508,687 5.800% | 176,236 (+53.01%) | Filing History |
| 2025-08-06 1:10 pm Purchase | 2025-07-22 | 13G | VERASTEM INC VSTM | Stonepine Capital Management, LLC | 2,833,333 5.000% | 630,000 (+28.59%) | Filing History |
| 2025-05-14 4:14 pm Purchase | 2025-03-31 | 13G | SURROZEN INC SRZN | Stonepine Capital Management, LLC | 332,451 9.900% | 87,793 (+35.88%) | Filing History |
| 2025-05-14 4:12 pm Purchase | 2025-03-31 | 13G | OPTINOSE INC OPTN | Stonepine Capital Management, LLC | 788,647 7.800% | 199,990 (+33.97%) | Filing History |
| 2025-05-14 4:10 pm Sale | 2025-03-31 | 13G | INOVIO PHARMACEUTICALS INC INO | Stonepine Capital Management, LLC | 1,434,997 3.800% | -481,669 (-25.13%) | Filing History |
| 2025-05-14 4:07 pm Sale | 2025-03-31 | 13G | CALCIMEDICA INC CALC | Stonepine Capital Management, LLC | 125,734 4.600% | -22,606 (-15.24%) | Filing History |
| 2025-05-14 4:04 pm Sale | 2025-03-31 | 13G | APREA THERAPEUTICS INC APRE | Stonepine Capital Management, LLC | 239,416 4.300% | -46,979 (-16.40%) | Filing History |
| 2025-02-25 5:16 pm Purchase | 2025-02-13 | 13G | EDESA BIOTECH INC EDSA | Stonepine Capital Management, LLC | 693,551 9.900% | 693,551 (New Position) | Filing History |
| 2025-02-13 12:38 pm Purchase | 2024-12-31 | 13G | OPTINOSE INC OPTN | Stonepine Capital Management, LLC | 588,657 5.900% | 43,682 (+8.02%) | Filing History |
| 2025-02-13 12:32 pm Sale | 2024-12-31 | 13G | VERASTEM INC VSTM | Stonepine Capital Management, LLC | 2,203,333 4.800% | -440,287 (-16.65%) | Filing History |
| 2025-02-13 12:15 pm Sale | 2024-12-31 | 13G | APREA THERAPEUTICS INC APRE | Stonepine Capital Management, LLC | 286,395 5.100% | -79,041 (-21.63%) | Filing History |
| 2025-02-13 12:07 pm Sale | 2024-12-31 | 13G | TELA BIO INC TELA | Stonepine Capital Management, LLC | 2,353,099 6.000% | -478,740 (-16.91%) | Filing History |
| 2024-12-23 8:08 pm Purchase | 2024-12-17 | 13G | INOVIO PHARMACEUTICALS INC INO | Stonepine Capital Management, LLC | 1,916,666 5.200% | 1,916,666 (New Position) | Filing History |
| 2024-12-13 2:55 pm Purchase | 2024-12-06 | 13G | CALCIMEDICA INC CALC | Stonepine Capital Management, LLC | 148,340 5.400% | 148,340 (New Position) | Filing History |
| 2024-11-20 5:21 pm Purchase | 2024-11-13 | 13G | OPTINOSE INC OPTN | Stonepine Capital Management, LLC | 544,975 5.400% | 544,975 (New Position) | Filing History |
| 2024-11-13 5:42 pm Purchase | 2024-09-30 | 13G | SURROZEN INC SRZN | Stonepine Capital Management, LLC | 244,658 7.300% | 45,500 (+22.85%) | Filing History |